QTRX Logo

Quanterix Corporation (QTRX) 

NASDAQ
Market Cap
$469.19M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
164 of 809
Rank in Industry
19 of 107

Largest Insider Buys in Sector

QTRX Stock Price History Chart

QTRX Stock Performance

About Quanterix Corporation

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Insider Activity of Quanterix Corporation

Over the last 12 months, insiders at Quanterix Corporation have bought $501,978 and sold $112,405 worth of Quanterix Corporation stock.

On average, over the past 5 years, insiders at Quanterix Corporation have bought $1.72M and sold $6.65M worth of stock each year.

Highest buying activity among insiders over the last 12 months: DONNELLY WILLIAM P (director) — $1.51M.

The last purchase of 20,200 shares for transaction amount of $501,978 was made by DONNELLY WILLIAM P (director) on 2023‑09‑08.

List of Insider Buy and Sell Transactions, Quanterix Corporation

2024-05-14SaleOLSON LAURIE Jdirector
1,500
0.004%
$16.98$25,470-3.36%
2024-04-01SaleOLSON LAURIE Jdirector
1,000
0.0026%
$23.50$23,500-30.57%
2024-02-14SaleOLSON LAURIE Jdirector
1,500
0.004%
$24.35$36,525-29.64%
2024-01-02SaleOLSON LAURIE Jdirector
1,000
0.0026%
$26.91$26,910-18.50%
2023-09-08PurchaseDONNELLY WILLIAM Pdirector
20,200
0.0545%
$24.85$501,978-6.20%
2022-08-12PurchaseToloue MasoudPresident & CEO
105,000
0.2829%
$10.43$1.1M+22.94%
2022-08-12PurchaseDOYLE MICHAEL ACFO and Treasurer
15,000
0.0394%
$10.16$152,418+22.94%
2022-08-11PurchaseHlavinka Sarah E.
4,760
0.0132%
$10.46$49,788+26.48%
2022-08-10PurchaseWALT DAVID R
150,000
0.4084%
$8.62$1.29M+50.00%
2022-08-10PurchaseMadaus Martin D
89,667
0.2385%
$8.43$755,543+50.00%
2022-08-10PurchaseMEISTER PAUL M
47,957
0.1303%
$8.61$412,780+50.00%
2022-08-01SaleToloue MasoudPresident & CEO
446
0.0012%
$15.61$6,964-15.97%
2022-08-01SaleFry John JGeneral Counsel & Secretary
401
0.0011%
$15.61$6,261-15.97%
2022-07-13SaleDOYLE MICHAEL ACFO and Treasurer
434
0.0012%
$18.16$7,879-30.22%
2022-07-05SaleHRUSOVSKY E KEVINExecutive Chairman
960
0.0024%
$16.57$15,906-29.13%
2022-07-05SaleToloue MasoudPresident & CEO
432
0.0011%
$16.57$7,158-29.13%
2022-07-05SaleFry John JGeneral Counsel & Secretary
387
0.001%
$16.57$6,412-29.13%
2022-06-13SaleToloue MasoudPresident & CEO
5,564
0.0153%
$15.27$84,955-15.21%
2022-06-02SaleHRUSOVSKY E KEVINExecutive Chairman
712
0.0019%
$17.47$12,441-27.36%
2022-06-02SaleFry John JGeneral Counsel & Secretary
378
0.001%
$17.47$6,605-27.36%

Insider Historical Profitability

24.07%
DONNELLY WILLIAM Pdirector
28438
0.0752%
$12.2610
OLSON LAURIE Jdirector
13738
0.0442%
$12.2604
CRANDELL KEITH
1537684
4.0648%
$12.2611<0.0001%
ARCH VENTURE FUND VI LP10 percent owner
1537684
4.0648%
$12.2610<0.0001%
WALT DAVID R
1431312
3.7836%
$12.2630+49.01%
HRUSOVSKY E KEVINExecutive Chairman
910249
2.4062%
$12.261103<0.0001%
Madaus Martin D
254633
0.6731%
$12.26152+50%
MEISTER PAUL M
252611
0.6678%
$12.2610+50%
Toloue MasoudPresident & CEO
185823
0.4912%
$12.2613+22.94%
Duffy David C.SVP R&D and CTO
54730
0.1447%
$12.26036
DOYLE MICHAEL ACFO and Treasurer
48614
0.1285%
$12.2611+22.94%
Fry John JGeneral Counsel & Secretary
37671
0.0996%
$12.26029
Mattoon DawnSr. VP, Diagnostics
36876
0.0975%
$12.26048
Chaubal AmolChief Financial Officer
30222
0.0799%
$12.26015
Orticerio ErnestSVP Finance and Corporate Dev
28802
0.0761%
$12.2605
Hlavinka Sarah E.
26270
0.0694%
$12.2610+26.48%
Roskey Mark T.SVP, Strategic Partnerships
22325
0.059%
$12.26045
Connolly John Mdirector
4970
0.0131%
$12.2610+26.86%
DRISCOLL JOSEPHChief Financial Officer
4388
0.0116%
$12.2606
DEKKERS MARIJN Edirector
2270
0.006%
$12.2615<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$73.57M8.163.12M-2.14%-$1.61M<0.01
AllianceBernstein$59.64M6.622.53M+351.8%+$46.44M0.02
Millennium Management LLC$53.37M5.922.27M+2.52%+$1.31M0.04
The Vanguard Group$48.76M5.412.07M+0.7%+$339,028.41<0.01
Lord Abbett$41.4M4.591.76M+22.85%+$7.7M0.14
Gilder Gagnon Howe & Co. LLC$27.66M3.071.17M-2.37%-$671,224.520.35
Portolan Capital Management$27.4M3.041.16M-10.35%-$3.16M2.1
Dimensional Fund Advisors$23.48M2.6996,636+2.31%+$530,689.000.01
Ashford Capital Management Inc$19.59M2.17831,535-0.04%-$8,246.002.66
Ameriprise Financial$19.43M2.16824,712+22.96%+$3.63M0.01
State Street$19.21M2.13815,487+0.8%+$151,749.96<0.01
Invesco$19.1M2.12810,532-6.84%-$1.4M<0.01
Geode Capital Management$18.83M2.09798,968+4.6%+$827,582.63<0.01
Emerald Advisers, Inc.$16.62M1.84705,447+22.8%+$3.09M0.68
Granahan Investment Management$15.83M1.76671,779+0.74%+$115,915.200.56
Baillie Gifford Co$14.69M1.63623,355-1.3%-$193,616.080.01
Tikvah Management Llc$13.47M1.49571,6190%+$04.24
Nuveen$13.39M1.49568,309+8.47%+$1.05M<0.01
EMERALD MUTUAL FUND ADVISERS TRUST$13.17M1.46558,841+17.96%+$2M0.69
Farallon Capital$11.1M1.23471,000+155.98%+$6.76M0.08
Renaissance Technologies$10.02M1.11425,386-10.39%-$1.16M0.02
Pura Vida Investments LLC$8.86M0.98375,985-42.27%-$6.49M6.31
Northern Trust$8.44M0.94358,405-2.1%-$180,658.08<0.01
Ubs Asset Management Americas Inc$8.03M0.89340,726+33.55%+$2.02M<0.01
Boone Capital Management Llc$7.78M0.86330,151-41.93%-$5.62M1.57
Charles Schwab$7.43M0.82315,383+6.62%+$461,116.29<0.01
Blue Water Life Science Advisors Llc$7.28M0.81309,093+7.25%+$492,333.326.85
D. E. Shaw & Co.$7.06M0.78299,746-51.59%-$7.53M0.01
Prudential Financial$6.75M0.75286,513-26.57%-$2.44M0.01
Pier Capital LLC$6.56M0.73278,491+32.21%+$1.6M0.91
Goldman Sachs$5.58M0.62236,731-18.67%-$1.28M<0.01
PLATINUM INVESTMENT MANAGEMENT LTD$5.12M0.57217,442-57.43%-$6.91M0.07
ROYCE & ASSOCIATES INC$5.09M0.56215,9480%+$00.05
Morgan Stanley$5.08M0.56215,832-38.31%-$3.16M<0.0001
Boothbay Fund Management LLC$4.28M0.48181,651-19.27%-$1.02M0.14
Parkman Healthcare Partners Llc$4.15M0.46176,112+20.32%+$700,815.810.51
Two Sigma Advisers LP$4.07M0.45172,548-26.96%-$1.5M0.01
Fuller & Thaler Asset Management, Inc.$3.73M0.41158,305-3.02%-$116,033.010.02
Bridger Management Llc$3.65M0.41154,9000%+$01.65
AQR Capital$3.48M0.39147,501+4.9%+$162,422.660.01
CWM LLC$3.2M0.36135,789-22.77%-$943,216.040.02
Marathon Micro Partners LLC$2.81M0.31119,135+12.66%+$315,468.450.68
BNY Mellon$2.73M0.3115,705-7.7%-$227,306.90<0.01
Bank of America$2.49M0.28105,793+92.94%+$1.2M<0.0001
ClariVest Asset Management LLC$2.46M0.27104,570-0.23%-$5,560.160.26
Oberweis Asset Management Inc$2.35M0.2699,700+13.55%+$280,364.000.17
JPMorgan Chase$2.2M0.2493,263+3.54%+$75,156.43<0.0001
Frontier Capital Management Co$2.2M0.2493,211-47.33%-$1.97M0.02
Picton Mahoney Asset Management$2.03M0.2386,092+1,598.07%+$1.91M0.1
China Universal Asset Management Co., Ltd.$2M0.2285,0190%+$00.18